The diagnostic and prognostic value of plasma microRNA-125b-5p in patients with multiple myeloma.

Jiang Yet al. Oncol Lett. 2018 Sep. doi: 10.3892/ol.2018.9128. [Epub 2018 Jul 11]

Prognostic value of [18F]FDG-PET/CT in multiple myeloma patients before and after allogeneic hematopoietic cell transplantation.

Stolzenburg A et al. Eur J Nucl Med Mol Imaging. 2018 Sep. doi: 10.1007/s00259-018-3997-0.

Determining treatment intensity in elderly patients with multiple myeloma.

Salvini M et al. Expert Rev Anticancer Ther. 2018 Sep. doi: 10.1080/14737140.2018.1496823.

Pre-diagnostic blood immune markers, incidence and progression of B-cell lymphoma and multiple myeloma: Univariate and functionally informed multivariate analyses.

Vermeulen R et al. Int J Cancer. 2018 Sep 15. doi: 10.1002/ijc.31536.

Early detection of multiple myeloma in primary care using blood tests: a case–control study in primary care

Koshiaris C et al. Br J Gen Pract. 2018 Sep. doi: 10.3399/bjgp18X698357. [Epub 2018 Aug 13]